Ars Pharmaceuticals, Inc. · NASDAQ:SPRY
Ra Capital Management, L.P. reported a 11.10% stake in Ars Pharmaceuticals, Inc. (Schedule 13D/A)
Event Sep 29, 2025 · Filed Oct 1, 2025
Ra Capital Management, L.P. reported a 11.10% stake in Ars Pharmaceuticals, Inc., 10,940,977 shares, with active intent on Sep 29, 2025. Filed Oct 1, 2025 (Schedule 13D/A).
- Stake
- 11.10%
- Shares
- 10,940,977
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| RA Capital Management, L.P. | 11.10% | 10,940,977 |
| Peter Kolchinsky | 11.10% | 10,940,977 |
| Rajeev Shah | 11.10% | 10,940,977 |
| RA Capital Healthcare Fund, L.P. | 10.10% | 9,958,073 |
Source
Related
- Ars Pharmaceuticals, Inc.
- Ra Capital Management, L.P.
- Ars Pharmaceuticals, Inc. shareholders
- Schedule 13G · BlackRock, Inc. · Jul 27, 2026
- Schedule 13G/A · Millennium Management LLC · Jul 14, 2026
- Form 4 · Karas Eric · Jun 12, 2026
- Form 4 · Fitzpatrick Alexander A · Jun 12, 2026
- Schedule 13G/A · Rubric Capital Management LP · May 15, 2026